DynaMesh®-PRM
DynaMesh®-PRM and DynaMesh®-PRM visible implants are intended to be used as a suburethral sling for the surgical treatment of male stress urinary incontinence. The devices permanently reinforce the soft tissue of the pelvic floor and permanently relocates the posterior urethra.
DynaMesh®-PRMProduct RangeUse and PropertiesVideosFurther Product Information
The device must be inserted via an appropriate perineal approach and is positioned suburethrally under tension, in a transobturator tape position using the outside-in technique.
DynaMesh®-IST02
Diameter: 7 cm
DynaMesh®-IST03
Diameter: 5 cm
DynaMesh®-IST02 / DynaMesh®-IST03:
Instrument set consisting of two instruments for transobturator positioning using the outside-in technique.
| DynaMesh®-PRM | 04 cm x 03 cm | PV330453F1 |
| DynaMesh®-PRM visible | 04 cm x 03 cm | PV730453F1 |
| FX = X unit(s)/box (e.g. F3 = 3 unit(s)/box) |
| Product | DynaMesh®-PRM (1) DynaMesh®-PRM visible (2) |
| Surgical Treatment | Male Stress Urinary Incontinence (SUI) |
| Sugical Approach | Perineal |
| Surgical Technique | Male Sling TOT – Transobturator – Outside-In |
| Fixation | Suture / Synthetic Adhesive |
| Smooth Warp-Knitted Selvedges |
 |
| Visible Technology |  (1) / (2) |
| Materials | – Polyvinylidene fluoride (PVDF) (CAS 24937-79-9) > 99% (w/w) (1) (2) – Phthalocyanine green (CAS 1328-53-6) < 1% (w/w) (1) – Triiron tetraoxide (CAS 1317-61-9) < 1% (w/w) (2) |
| Polymer (Monofilament) | PVDF |
| Biocompatibility |
[TR1] |
| Ageing resistance |
[2A, 5VIT, 27A, 52VIT, 93A, 101] |
|
Applicable |
|
Does not apply |
| [#] | Reference “#” (see “References”) |
| [TR#] | Internal test report (see “internal test report references”) |
| Limitations | “A” animal trial, “B” bench test, “VIT” in-vitro trial, “P” published results based on the analysis of human mesh explants, “PB” published results mainly based on bench tests |
